Analyst firms · Morgan Stanley · KOD

Morgan Stanley KOD price target and rating history

Kodiak Sciences Inc (KOD) · Health Care

Morgan Stanley rates Kodiak Sciences Inc (KOD) Equal-Weight with a $17 price target, as of its latest action on Feb 24, 2022. It has published 3 rating actions on KOD since January 2022, including 0 upgrades and 0 downgrades.

Current rating
Equal-Weight
Price target
$17
Median target, all firms
Too few
Actions on KOD
3

Morgan Stanley price target on KOD

$122$70$172023202420252026
Morgan Stanley price target on KOD, each point a stated target, January 2022 to February 2022.

Every Morgan Stanley rating on KOD

How other firms rate KOD

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Goldman SachsNeutral$36Sep 24, 2026
Chardan Capital MarketsBuy$61May 11, 2026

Questions about Morgan Stanley and KOD

What is Morgan Stanley's price target for KOD?
Morgan Stanley's latest stated price target for Kodiak Sciences Inc (KOD) is $17, from its action on Feb 24, 2022.
What is Morgan Stanley's rating on KOD?
Morgan Stanley rates KOD Equal-Weight, a neutral rating, as of Feb 24, 2022.
When did Morgan Stanley last change its view on KOD?
On Feb 24, 2022, Morgan Stanley cuts its price target to $17 from $77, keeps Equal-Weight.

More KOD rating histories

All Morgan Stanley ratingsKOD news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.